Tarsus Pharmaceuticals, Inc. (TARS) has 15 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 6 sales totalling $4.9M. Most recent filing: Sept. 17, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 17, 2026 filed Sept. 15, 2026 | PYOTT DAVID E I Director | $0 | 402 | +50% | No | |
|
|
||||||
| Sept. 17, 2026 filed Sept. 15, 2026 | YARNO WENDY L Director | $0 | 604 | +50% | No | |
|
|
||||||
| Sept. 17, 2026 filed Sept. 15, 2026 | LINK WILLIAM J PHD Director | −$963,990 | 12,902 | −95% | Yes | |
|
|
||||||
| Sept. 9, 2026 filed Sept. 4, 2026 | Azamian Bobak R. President/CEO and Board Chair | −$905,600 | 10,000 | −1% | Yes | |
|
|
||||||
| Sept. 9, 2026 filed Sept. 4, 2026 | Lin Elizabeth Yeu Chief Medical Officer | −$1,220,885 | 13,953 | −90% | Yes | |
|
|
||||||
Showing the 5 most recent of 15 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free